Trials / Recruiting
RecruitingNCT07160153
Cannabis Abstinence and Neurocognitive Assessment in Adolescence
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 29 (estimated)
- Sponsor
- University Hospital Pilsen · Academic / Other
- Sex
- All
- Age
- 15 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
Cannabis Abstinence and Neurocognitive Assessment in Adolescence
Detailed description
Evaluate the development of cognitive functions following attainment of abstinence in a group of adolescents with cannabis dependence or harmful cannabis use. Abstinence is confirmed by toxicological testing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Neurocognitive assessment | Neurocognitive battery: TMT-Trail Making Test Auditory Verbal Learning Test Stroop Test Tower of London (ToL), Shallice version Continuous Performance Test-Identical Pairs Other psychometrics: The level of dependence is quantified using the CAST (Cannabis Abuse Screening Test) |
| DIAGNOSTIC_TEST | Urine toxicological assessment | Urine toxicological assessment |
Timeline
- Start date
- 2024-12-03
- Primary completion
- 2028-12-31
- Completion
- 2029-08-31
- First posted
- 2025-09-08
- Last updated
- 2025-09-19
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT07160153. Inclusion in this directory is not an endorsement.